The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals

Metabolic diseases are the most common and rapidly growing health issues worldwide. The massive population-based human genetics is crucial for the precise prevention and intervention of metabolic disorders. The China Metabolic Analytics Project (ChinaMAP) is based on cohort studies across diverse regions and ethnic groups with metabolic phenotypic data in China. Here, we describe the centralized analysis of the deep whole genome sequencing data and the genetic bases of metabolic traits in 10,588 individuals from the ChinaMAP. The frequency spectrum of variants, population structure, pathogenic variants and novel genomic characteristics were analyzed. The individual genetic evaluations of Mendelian diseases, nutrition and drug metabolism, and traits of blood glucose and BMI were integrated. Our study establishes a large-scale and deep resource for the genetics of East Asians and provides opportunities for novel genetic discoveries of metabolic characteristics and disorders.


INTRODUCTION
Metabolic diseases are becoming a major growing public health challenge and causes of morbidity and mortality in the world. The most common and important metabolic diseases, type 2 diabetes and obesity, are comprised of different subtypes requiring specific diagnosis and treatments. Understanding the genetic architecture of metabolic traits is crucial for individual risk assessment, prevention, and treatment of metabolic diseases. Applying a comprehensive genetic analysis of massive cohorts can provide a systematic approach and effective strategy for the discovery of novel markers and targets. The variant spectrum of coding and non-coding regions from population genomics promotes a further understanding of the genetic basis of complex metabolic traits and diseases. The findings from the genome-wide association studies (GWAS) and population genome sequencing projects construct the knowledge of variants associated with metabolic traits. 1,2 Large-scale reference datasets of population-specific genomics are fundamental for drug development and precision medicine of Mendelian and common diseases. Importantly, common metabolic traits and diseases are characterized by genetic heterogeneity in population groups. 1, 3 The populations in the Europe and USA have magnificent databases of human genomics and bioinformatics, including the UKbiobank, 4 The Genome Aggregation Database (gnomAD), 5 1000 Genomes Project (1KGP), 6 deCODE genetics, 7 the UK10K project, 8 the DiscovEHR 9 and Trans-Omics for Precision Medicine (TOPMed) Program. 10 Recently, two studies reported population genomic dataset from Chinese non-invasive prenatal testing and Singapore Chinese population. 11,12 However, the low-depth sequencing data in these datasets limit the quantity of high-quality variants and accuracy of individual variants, especially rare variants. Considering the huge differences of genetic background and population characteristics between East Asians and Europeans, 13 and the lack of high-depth Chinese cohort genomic study, representative database from Chinese cohorts is a critical part for the missing diversity.
Here, we describe the genomic dataset and analysis of 10,588 deep whole genome sequencing (WGS) data from The China Metabolic Analytics Project (ChinaMAP). The ChinaMAP was designed to comprehensively characterize the diverse genetic architectures of Chinese Han and major ethnic minorities across different geographical areas, and investigate their contribution to metabolic diseases and a broad spectrum of biomedically relevant quantitative traits.

High-depth WGS dataset of the ChinaMAP
The ChinaMAP is based on three large-scale cohorts: The China Noncommunicable Disease Surveillance 2010, a nationally representative study with 150,000 participants; 14 the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REAC-TION) study with 250,000 participants 15 and the Communitybased Cardiovascular Risk During Urbanization in Shanghai with 50,000 participants. 16 A wide variety of phenotypic information, as well as biological samples, has been collected for each of 450,000 participants. These cohorts are followed periodically for new cases of diseases and disease complications. In the first phase of the ChinaMAP, we have randomly selected participants from 8 ethnic populations (Han, Hui, Manchu, Miao, Mongolian, Yi, Tibetan and Zhuang) across 27 provinces of China without biased selection or filtration, and completed the analysis of deep WGS data (40.80×) from 10,588 participants. The mean baseline age was 54 years and 64.8% were women (Supplementary information, Fig. S1a and Table S1).
High-depth WGS data (> 30×) is necessary for accurate detection of extremely rare variants. 17 The ChinaMAP obtained a more massive Chinese genomic dataset compared to the lowdepth genome data from non-invasive prenatal testing and SG10K study. 11,12 The final database contained 136. 75 Table S3). The remaining 98.79% of variants are noncoding variants, for which there is still a lack of functional analysis and annotation. The quantity distribution and density of autosomal SNPs were analyzed (Supplementary information, Fig. S1c).
To ensure the information from the ChinaMAP are available to researchers, we established the ChinaMAP browser (www. mBiobank.com) for investigations as other large-scale human genomic sequencing projects, such as the DiscovEHR browser (http://www.discovehrshare.com) 6 and the Bravo browser (https:// bravo.sph.umich.edu). 10 The summary information from the databases, including the position, reference allele, mutated allele and allele frequencies of all variants could be accessed through the ChinaMAP browser. All variants could be inquired by gene symbol, rs ID, genomic region or position. The exact number of alleles, allele frequency data in different ethnic groups and data quality for each variant from the ChinaMAP could be searched on the mBiobank website.
To analyze the novel genetic characteristics and information of the Chinese population, we compared the ChinaMAP dataset to the TOPMed (freeze 5, 463 M variants), gnomAD (v2.0.2, 125,748 exomes and 15,708 genomes), dbSNP (v149) and 1KGP. The ChinaMAP dataset exhibited great differences compared to the combination of TOPMed, gnomAD, dbSNP and 1KGP (Fig. 1c, ), which is a key region for the Silk Road and migration of ancient ethnic groups in history, 18 have noticeably more individual variants (Fig. 1e) Fig. S3e). Taken together, these genomic analyses revealed the genetic characteristics, diversity and complexity of the multi-ethnic Chinese population in large geographical areas.
To analyze the conservation of noncoding genome sequence and variants, we calculated the difference of observed variation from expected variation by the context-dependent tolerance score (CDTS) and ranked every 550 bp sliding window regions to study the context-dependent constrained regulatory regions using 16,384 unique heptamers (7-nt motifs) in the human genome. 19 Our results showed the strong functional enrichment for non-coding variants in regulatory regions such as promoter and enhancer, similarly as reported (Fig. 2a, b).

Loss-of-function and pathogenic variants
The identification and frequency spectrum of deleterious pathogenic and predicted loss-of-function (pLOF) variants contribute to the crucial reference for Mendelian disorders . The ChinaMAP  dataset contains 82,969 pLOF variants, including 48,163 SNPs and  34,806 INDELs (Supplementary information, Table S2). More than half of the pLOF variants are novel rare variants (7631) and singletons (38,490). The total of 792 common and 424 lowfrequency (AF > 1%) pLOF variants included 21 novel variants. The majority of protein-coding genes (15,048 in 18,502 known genes, 81.3%) have rare pLOF variants (AF < 1%) in at least one participant (Supplementary information, Table S5). In addition, the analysis of 'human gene knockouts' 20 revealed that 627 genes and 29 LOF intolerant genes contained homozygous rare pLOF variants in at least one participant, which could contribute to human population-based data of gene functions (Supplementary information, Fig. S4a and Tables S5 and 6). The count numbers and spectrum of allele frequencies showed that the pLOF variants were much fewer than others under the negative selection ( Fig. 3a and Supplementary information, Fig. S4b). 9, 21 The OP (observed to potential) ratio of predicted truncating mutations indicated that the natural selection restrained pLOF variants were less tolerant with the increase of allele frequency (Supplementary information, Fig. S4c). The pLOF variants in cancer and autosomal dominant disease-associated genes were more intolerant than the variants in olfactory receptor genes, drug target genes and autosomal recessive disease-associated genes (Fig. 3b) To assess the characteristics and distribution of causal variants for Mendelian disorders in the ChinaMAP, we filtered the pathogenic variants with the annotation of ClinVar database (20180603) 22,23 and HGMD (Human Gene Mutation Database, 2016.2), 24 and further analyzed the disease-causing variants following the guidelines from the ACMG (American College of Medical Genetics and Genomics). 25 A total of 2026 variants or 1619 variants in the HGMD DM set were annotated as pathogenic or likely pathogenic by the ClinVar or ACMG, respectively ( Fig. 3c and Supplementary information, Table S7). The candidate pathogenic variants should be defined and interpreted by further clinical and functional investigations. The pathogenic variant with the highest allele frequency in the ChinaMAP was identified as SERPINB7 rs142859678 (AF = 0.011). The rs142859678 in SERPINB7 (AF = 5.16 × 10 −4 , gnomAD) causes the autosomal recessive disease Nagashima-type palmoplantar keratosis, which is reported in Chinese and Japanese populations. 26 We also identified that SPINK1 rs148954387 (AF = 5.38 × 10 −3 ), a variant that leads to chronic pancreatitis, 27 had a higher frequency in China (AF = 2.99 × 10 −4 , gnomAD). Moreover, we noticed that the pathogenic   variants in 6 genes (DUOX2, DUOXA2, SLC26A4, TG, TRHR, and TSHR) related to thyroid function were more common in the ChinaMAP than gnomAD ( Fig. 3d and Supplementary information, Table S8). We found 12 individuals with homozygous or two heterozygous mutations in these genes (Supplementary information, Table S9), which could cause congenital hypothyroidism. 28 These genetic epidemiology findings revealed the potential importance of genetic testing screening for Mendelian disorders with high incidence. The frequency spectrum of variants in the ChinaMAP (Supplementary information, Table S7) provides an additional reference for the studies of variants of uncertain significance (VUSs). Polygenic risk score and WGS association analyses The advance of deep WGS data and the diversity of Chinese population empower the ChinaMAP for the discovery of novel functional rare and population-specific variants in East Asian ancestry. 30 Therefore, we performed the polygenic risk score (PRS) profiling for individual genetic risk estimation, 31,32 single variant association analysis and sequence kernel association test (SKAT) for rare variant association analysis.
We investigated the PRSs for the most common metabolic traits, fasting blood glucose (FBG) and 2-hour postprandial blood glucose (2h-PBG). The recent large-scale meta-analysis data of GWASs from East Asian populations 33 and European populations 34 were used separately as base datasets for the PRS calculation of the target data from the ChinaMAP. The combination ranking of  (Fig. 6c, f). Comparison of the data from base datasets of East Asian (Fig. 6a- (Fig. 6g). The area under the receiver-operator curve (AUC) analysis indicated that the risk prediction of type 2 diabetes was feasible (Fig. 6h, i). These findings supported the value of PRS and the importance of base datasets from East Asian cohorts for the precise individual genetic risk estimation of metabolic diseases. The large proportion of novel variants from the ChinaMAP data could facilitate the discovery of novel variants and genes in the WGS association analyses of metabolic traits. 35, 36 We performed single variant association analysis and SKAT analysis of BMI, FBG and 2h-PBG by the EPACTS software (Fig. 7a, b). Our results from the blood glucose analysis validated well-established gene loci associated with type 2 diabetes with common SNPs in CDKAL1, SLC30A8, SND1-PAX4, IDE-KIF11-HHEX, CDKN2A-CDKN2B, KCNQ1 and CDC123, 33,37,38 and identified a novel locus associated with FBG in DENND5B ( Fig. 7a; Supplementary information, Table S10). We also identified novel Asian-specific SNPs associated with BMI (rs369036035, P = 1.72 × 10 −25 and rs372115169, P = 1.55 × 10 −16 ) in CADM2 (Fig. 7a; Supplementary information, Table S11), which mediates synaptic signaling in the brain and regulates body weight and energy homeostasis. 39 In the SKAT analysis, rare functional variants including pLOF variants and missense variants predicted to be deleterious by MetaSVM, SIFT and PolyPhen2 were analyzed (Fig. 7b, c; Supplementary information, Table S12). Interestingly, we identified that the gene TBX21, which encodes the immune cell transcription factor T-bet, was significantly associated with BMI (P = 3.5 × 10 −10 ) (Fig. 7b). Consistently, the deficiency of T-bet in mice increased body weight and insulin sensitivity. 40 We also detected a significant signal of PLCB3 in the BMI analysis (P = 4.39 × 10 −8 ). Novel association between the coding variant (rs35169799) of PLCB3 and type 2 diabetes and body-fat distribution were reported recently. 41,42 Furthermore, we identified the MAFA (P = 1.34 × 10 −11 ), MTMR9 (P = 4.45 × 10 −7 ) and PAX6 (P = 3.39 × 10 −15 ), ANGPTL4 (P = 1.26 × 10 −6 ), and SOX4 (P = 9.46 × 10 −7 ) in the analysis of FBG and 2h-PBG (Fig. 7b, c). MafA, Pax6 and Sox4 are all critical transcription factors controlling       Article insulin production and secretion in pancreatic β-cells. [43][44][45] Missense mutations of MAFA gene were found in familial hypoglycemia or diabetes. 46 The association between ANGPTL4 variants and type 2 diabetes and the underlying mechanism, and the association between MTMR9 and obesity were reported. 47,48 In addition, ORM1, which encodes the key acute phase plasma protein orosomucoid 1, was markedly associated with FBG (P = 2.52 × 10 −14 ). The circulating orosomucoid could decrease food intake and regulate energy homeostasis via leptin receptor signaling in obese and diabetic mouse models. 49 Taken together, our findings provided novel variants and genes for candidate association of metabolic traits.
Genetic evaluation of individual metabolic characteristics Genetic evaluation and interpretation of metabolic features based on deep WGS data is a potential utility for individual health management. We explored the epidemiology and geographical characteristics of nutrition and drug metabolism in the ChinaMAP participants. Drinking alcohol and coffee are the most common dietary habits associated with health status. 50,51 We analyzed the frequency and distribution of several critical SNPs in ALDH2 (rs671) and ADH1B (rs1229984 and rs2066702) for alcohol metabolism and dependence (Fig. 8a). The data revealed that the Chinese population generally had a markedly lower clearance rate of alcohol compared to European and African ancestries ( Fig. 8a; Supplementary information, Table S13). The individuals with homozygous (4.50%) and heterozygous (34.27%) ALDH2 rs671, which is associated with the 'Asian Blush', have a higher risk of acetaldehyde accumulation and esophageal cancer. 50 Geographically, the populations from the North have a stronger ability of alcohol metabolism than those from the South in China; individuals from ethnic minorities Tibetan, Mongolian and Yi are top-ranked, whereas those from Lingnan Han and Southeast Han ranked bottom (Supplementary information, Fig. S7a-c). The ability of caffeine metabolism is similar in different regions. The allele frequency of CYP1A2 rs762551 for caffeine metabolism was comparable between the Chinese populations and other ancestries ( Fig. 8a; Supplementary information, Fig. S7d). The genetic tests for the use of anticoagulant and antiplatelet drugs are the common clinical applications of pharmacogenomics. We performed the therapeutic classification and calculated the dosage of warfarin and clopidogrel in all individuals according to  53 The analysis of SNPs in CYP4F2, VKORC1 and CYP2C9 indicated that almost all Chinese should reduce the dosage of warfarin (Fig. 8a). The majority of individuals should have a dose reduction of~2-3 mg/day (Supplementary information, Fig. S7e) on the basis of warfarin dosing algorithms (average 5 mg/day). The analysis of CYP2C19 genotypes revealed that more than half of the Chinese individuals (59.08%) were intermediate (IMs, 46.02%) and poor metabolizers (PMs, 13.06%) of clopidogrel, who should consider therapies with alternative antiplatelet agents ( Fig. 8a; Supplementary information, Fig. S7f and Table S14). Moreover, we examined the SLCO1B1 variants to estimate the genetic risk of simvastatin-induced myopathy 54 Table S15). In summary, these data reminded the necessity of individual genetic testing for reducing the side-effects of common drugs in China. All of the genetic characteristics and geographical distribution of 10,588 individuals in the ChinaMAP were integrated into a circus for an overview of the genetic diversity in the Chinese population (Fig. 8b).

DISCUSSION
The genetic architecture of metabolic traits and variant associations for metabolic diseases are mainly from GWASs and exome sequencing studies of largely European ancestry cohorts. 1,13 Human genomics from diverse ancestry populations are required for further understanding of the etiology of common metabolic diseases. The large-scale investigations on genetic characteristics of East Asian ancestry could promote the discovery and development of innovative risk assessment, prevention, and therapeutic strategies for metabolic diseases and complications. The population genomics of East Asian also could provide insights into the evolution and epidemiology of metabolic diseases. N o r th w e s t H a n C e n tr a l H a n L in g n a n H a n S o u th H a n N o r th H a n E a s t H a n S o u th e a s t H a n M o n g o li a n M a n c h u T ib e ta n H u i Z h u a n g Y i M ia o Frequency N o r th w e s t H a n C e n tr a l H a n L in g n a n H a n S o u th H a n N o r th H a n E a s t H a n S o u th e a s t H a n M o n g o li a n M a n c h u T ib e ta n H u i Z h u a n g

Article
The ChinaMAP is based on established large cohorts across China, which represents the well-powered natural population for the investigations of factors associated with metabolic traits. The ChinaMAP has constructed a large and high-quality genomic dataset for the discovery of novel functional variants and highimpact genes and pathways in metabolic diseases. The ChinaMAP dataset exhibits great differences and contributes a large proportion of novel variants (68.3 M variants, 49.9%) compared to the combination of TOPMed, gnomAD, dbSNP and 1KGP datasets (Fig. 1), which is promising for the discovery of population-specific functional variants associated with diseases. The successful strategies in the genetic studies of specific populations had identified key genes in participants with type 2 diabetes 55 or low plasma LDL cholesterol level. 56 The ChinaMAP dataset could be a unique   Fig. 7 WGS association analysis of BMI and blood glucose. a Manhattan plots for common and low-frequency single variant association analysis of BMI, FBG and 2h-PBG. Redline is P = 5 × 10 −8 . b Manhattan plots for the gene-based association analysis of BMI, FBG and 2h-PBG. Redline is P = 2.5 × 10 −6 . c The significant signals identified in the SKAT analysis are shown in genes TBX21, MAFA, ANGPTL4, PAX6, MTMR9, ORM1 and SOX4.
Article resource and reference for the investigation and identification of candidate disease-causing and disease-associated variants. Importantly, the frequency spectrum of VUSs in the ChinaMAP (Fig. 3; Supplementary information, Table S7) is also a valuable reference for the determination of causal variants of Mendelian diseases. 57, 58 The population-specific deleterious variants in the ChinaMAP might contribute to the discovery of rare high-impact variants in common metabolic diseases. In the ChinaMAP, the population structure analysis demonstrated the complexity and features of genetic background in Chinese Han and minority ethnic groups across geographic regions (Figs. 4 and 5). The ethnic groups of East Asian ancestry in the ChinaMAP showed unique population genomic characteristics and large difference compared to other populations, as described before. 11,12 Importantly, the ChinaMAP dataset revealed the genomic characteristics and relationships of Chinese Han and major ethnic minorities. Our data demonstrate that the Chinese Han population could be mainly distinguished into 7 population clusters, including Northwest Han, North Han, East Han, Central Han, Southeast Han, South Han and Lingnan Han (Fig. 4d). The previous classification of North and South Han (CHB and CHS) populations mainly represent a part of the Chinese Han, including North Han, Southeast Han and Lingnan Han. The PCA analysis from previous report 12 demonstrated that the Singapore Chinese population was mainly overlapped with CHS, and our results showed that CHD was close to Chinese Han populations in east and south coastal provinces. These findings indicated the complexity and diversity of Chinese genomic characteristics, and that the current genomic dataset from Chinese populations abroad only represent the historical Chinese Han migrations from South and East China populations. Furthermore, the genetic diversity and population structures suggest that further construction of Chinese imputation reference panel would contribute to the genotype imputation quality in East Asian ancestry.
Currently, the established knowledge and guidelines related to medical genomics are mainly from Eurocentric resources, which are accepted and applied worldwide. The definition and interpretation of candidate pathogenic variants identified by databases with Eurocentric biases would require specific dataset, clinical and functional studies for East Asians. However, East Asianspecific studies are still limited due to lack of in-depth and wellphenotyped genomic database from cohort studies. The China-MAP provides a large and high-quality database for East Asian populations, which is beneficial for clinical investigation, validation and follow-up studies in the future. The East Asian-specific and novel variants from known disease-related genes in the ChinaMAP could be systematically investigated by future studies for genomic applications in East Asians, including clinical pharmacogenomics and genetic counseling.
The personal health management and disease risk assessment are core features for precision medicine. For the prevention and intervention of metabolic diseases, the individual-level genetic risk estimation by PRSs is a practical approach based on comprehensive genotype and phenotype database. 32 For example, a recent study used PRS approach for precise, early risk detection of obesity based on a large cohort GWAS study. 59 In this work, we showed that the PRS analysis was effective for individual risk evaluation of type 2 diabetes in the Chinese population. Notably, our findings showed that the PRS of Chinese population should be calculated according to East Asian-specific data by comparison of results based on GWAS studies from East Asian and European populations ( Fig. 6; Supplementary information, Fig. S6). In addition, we identified and validated reported and novel gene loci associated with BMI and blood glucose through WGS association analysis (Fig. 7). The expansion of sample size and establishment of the base dataset of East Asians in the future would promote the precise clinical utility of PRS in the prevention of metabolic diseases. Furthermore, the personal and population scale genetic analysis of nutrition and drug metabolism for the ChinaMAP participants provided the individual and epidemiological information for metabolic characteristics (Fig. 8).
Collectively, the comprehensive database and genetic characterization of individuals from large well-phenotyped cohorts in the ChinaMAP could contribute to the molecular typing, prevention and individual management of metabolic diseases. Library construction and WGS Library construction and WGS were performed at BGI-Genomics. Sequence libraries for the BGISEQ-500 platform were prepared based on the BGISeq-500 library construction protocol. The qualified genomic DNA sample was randomly fragmented by Covaris technology and the DNA fragments were selected by size. The end-repair of DNA fragments was added an 'A' base at the 3′end of each strand. BGISEQ-500 adapters were ligated to both ends of the A-tailed fragments, followed by amplification by ligation-mediated PCR (LM-PCR), single strand separation and cyclization. The rolling circle amplification (RCA) was performed to produce DNA Nanoballs (DNBs). The qualified DNBs were loaded into the patterned nanoarrays and processed for 100 bp pair-end sequencing on the BGISEQ-500 platform. Sequencing-derived raw image files were processed by the BGISEQ-500 base calling software with default parameters.
All sequencing data were subjected to a series of quality control before further analysis with criteria: (1) base quality (Q30) > 80%; (2) mean sequence depth > 30×; (3) mapping rate ≥ 95%; (4) mismatch rate < 1%; (5) duplicate rate < 10%; (6) 20× coverage > 80%. In addition, mass spectrometric fingerprint genotyping of 21 common SNPs was used to verify that DNA sample and the sequencing data were from the same individual. The gender of every sample was inferred based on sequencing data by GATK TargetCoverageSexGenotyper (v4.beta.4). The inferred gender of sequencing data should be consistent with the clinical information. In total, 10,588 WGS data passed the quality control.
Computing environment, variant calling and annotation Three analysis platforms were used for the ChinaMAP data analysis. The same analysis pipeline was deployed on the SGE of Alibaba Cloud, the BGI HPC Cluster and BGI Online. The testing sequencing data of 50 samples were reanalyzed for 10 times on each analysis platform for consistency and stability. Discovery of germline short variants (SNPs and INDELs) was implemented according to the GATK Best Practice recommendations. We used the GATK HaplotypeCaller (v4.0.4.0) to call variants per sample and produced an intermediate file in GVCF format and consolidated GVCF files from 10,588 samples into one GVCF file using the GATK CombineGVCFs (v4.0.4.0). When we combined the GVCF files, the low-complexity regions (LCRs, covering 2% of the genome and identified by the mDust program) 63 were ignored. Based on the combined GVCF file, the joint call was performed using the GATK GenotypeGVCFs LOF variant definition and OP ratio calculation Variants predicted to be stop codons, essential splice sitedisrupting, initiator codon, start lost, transcript ablation and frameshift variants are defined as LOF variants. The OP ratio is a gene-based metric to quantify LOF variation while accounting for transcript size and is a useful tool for comparing the rate of LOF variation in different gene groups. It is designed to measure a gene's tolerance to damaging amino-acid changes. The OP ratio was calculated by comparing the observed and the potential numbers of LOF sites based on dbNSFP database. 65,66 Estimation of natural selection The site frequency spectrum (SFS) was calculated by counting the number of variants that exist in i for i = 1, 2,…, n-1, in a sample of size n. The fraction of variants under purifying selection was calculated by the python scripts 67 using LOF, non-synonymous and synonymous SFS, respectively. Intron and intergenic sites were used as a reference. Variant frequency data of other populations were obtained from IKGP (n = 2504 for all races, n = 504 for East Asian and n = 208 for CHB and CHS), TOPMed and gnomAD.
Population structure analysis PCA was performed using a subset of autosomal bi-allelic SNPs. Several restrictions were employed to select the final 1,409,151 SNPs for PCA analysis, including minor allele frequency (MAF) ≥ 1% (common and low-frequency variants), genotyping rate ≥ 90%, Hardy-Weinberg-Equilibrium (HWE) P > 0.000001, and removing one SNP from each pair with r 2 ≥ 0.5 (in windows of 50 SNPs with steps of 5 SNPs). The PCA was performed with the final SNPs using PLINK 68 (v1.9) and EIGENSOFT 69,70 (v7.2.1). When compared to 1KGP and CHD population in HapMap, the overlapping 124,900 SNPs between the ChinaMAP, 1KGP and CHD in HapMap Project were used for PCA analysis. Restricting PCA of CHD in HapMap, EAS populations in 1KGP and ChinaMAP was based on the overlapping 124,900 SNPs.
We also used the ADMIXTURE 71 (v1.3.0) to estimate the individual ancestries, with the number of ancestral component K values ranging from 2 to 12. To obtain the optimal K value, we divided our data into 5 roughly equal parts. For each k = 1, 2,…5, we fitted the model with parameter λ to the other 4 parts, givinĝ β Àk ðλÞ, and computed its error in predicting the kth part: The five-fold cross-validation error was computed: CV λ ð Þ ¼ 1 5 P 5 k¼1 E k ðλÞ. Using the above formulas, we chosen the optimal K value that makes CV(λ) smallest. We calculated the mean pairwise Fst differences between different population groups in the HapMap and ChinaMAP cohorts by using EIGENSOFT (v7.2.1).

Familial relationship of individuals
The relatedness of individuals was analyzed by the genotypes for 1,409,151 SNPs of each sample. SNPs were the same as in the ChinaMAP PCA analysis. Relatedness of the samples were measured by IBD (Identical by Descent) using PLINK 68 (v1.9). Unrelated participants were identified using the proportion of relatives of PI_HAT < 0.1875. A total of 9847 unrelated participants without family relationships were determined in the ChinaMAP.

PRS analysis
We performed PRS calculations on individual blood glucose using the PRSice software. 72 Two independent GWAS datasets were used for PRS calculation: (1) results from a GWAS study for type 2 diabetes including 433,540 East Asian individuals; 33 (2) results from a GWAS study 34 for type 2 diabetes (898,130 individuals of European ancestry), and we only used the comparable variants in a GWAS study from Japanese population. 73 We evaluated 5 main approaches to generate weighted PRSs: (1) converting genome coordinates from hg19 to hg38 for GWAS datasets; (2) only inclusion of genome-wide significant variants (P < 5 × 10 −8 ); (3) removing linkage disequilibrium (LD); (4) exclusion of A/T and C/G SNPs to minimize errors from strand flips; (5) adjusting by age, age 2 , gender and the first two principal components of ancestry. We labeled the top 10% PRS of individuals as the top group, the last 10% PRS of individuals as the tail group, and the remaining intermediate PRS of individuals as the median group. We used the two-tailed t-test to compare the differences between the top, median and tail groups. The relationship of the top group with type 2 diabetes was determined using logistic regression. The AUC was calculated to assess the performance of the binary trait.
Genotype-phenotype association analysis The measurement and collection of phenotype information for all individuals are described previously. 14,16,63 Before genotypephenotype association analyses, all variants were subjected to a series of quality control with criteria: (1) median depth > 8; (2) within LCRs (< 7 single base repeat units); (3) homozygous variants (AF ≥ 0.90); (4) homozygous variants (AF ≥ 0.2); (5) genotyping rate ≥ 90%; (6) HWE > 0.000001. 4,764,593 SNPs passed the quality control. Genotype-phenotype association analyses were performed using the EPACTS with EMMAX (Efficient Mixed Model Association eXpedited) model (https://genome.sph.umich.edu/ wiki/EPACTS). Empiric kinship matrix were based on 1,372,394 common and low linkage SNPs (retaining one SNP from each pair with r 2 < 0.5 in windows of 50 SNPs with steps of 5 SNPs) in autosomal chromosomes. Kinship matrix was performed by EPACTS default parameters ("make-kin"). The single variant association analyses with common (MAF > 5%) and lowfrequency (1% < MAF ≤ 5%) variants were performed by adjusting for age, age 2 , gender, the first two principal components of ancestry and an empirically derived kinship matrix for familial and distant relatedness. The statistical significance threshold for single variant EMMAX association analysis was 5 × 10 −8 . The SKAT analyses with rare variants (MAF < 1%) were performed using the mixed-model SKAT implementation in EPACTS. The rare variants in coding regions for analyses were selected using LOF variants and deleterious missense variants predicted by MetaSVM, SIFT and PolyPhen2. 120,262 SNPs in 17,156 genes were produced in the analysis process. The SKAT analyses were performed by adjusting for age, age 2 , gender, two principal components of ancestry and an empirically derived kinship matrix. The gonadalspecific expression genes were removed. The statistical significance threshold for each test was 2.5 × 10 −6 (0.05/20,000).

CDTS analysis
We used CDTS analysis, which depends on the difference between the observed and expected scores, to analyze the whole genomewide variants. Because there are 16,384 heptamer (7-nt motifs) sequences in the genome, every nucleotide was part of a heptamer, and every single position could be used in the corresponding genome-wide computed scores. The observed regional tolerance score was the number of SNPs (AF > 0.0001) in the studied population in a defined region. In the same region, the expected regional tolerance score was the sum of the heptamer tolerance scores. All the autosomal SNPs were used for the CDTS analysis, except INDELs. Genomic regions were then ranked by their CDTSs. The lowest context-dependent tolerance to variation was the regions with the lowest rank (1st percentile). The highest context-dependent tolerance to variation was the regions with the highest rank (100th percentile). The genomic element region file was provided by the authors of CDTS method. 19 Pharmacogenetic analysis Pharmacogenetic analysis was performed based on the PharmGKB database and the CPIC guidelines. For the warfarin dosing calculation, the CYP2C9 and VKORC1 genotypes were analyzed for the dosing algorithm of warfarin. 53 CYP2C9 and VKORC1 allele definition table was downloaded from CPIC website. Warfarin pharmacogenetic dosing algorithm is the following formula: 5.6044 − 0.2614 × Age + 0.0087 × Height (cm) + 0.0128 × Weight (kg) − genotype dosing = Square root of weekly warfarin dose, in which, genotype dosing = −0.8677 × VKORC1 rs9923231 A/G -1.6974 × VKORC1 rs9923231 A/A -0.4854 × VKORC1 genotype unknown -0.5211 × CYP2C9*1/*2 -0.9357 × CYP2C9*1/*3 -1.0616 × CYP2C9*2/*2 -1.9206 × CYP2C9*2/*3 -2.3312 × CYP2C9*3/*3 -0.2188 × CYP2C9 genotype unknown.
The status of simvastatin metabolism was evaluated by SLCO1B1 genotypes following the CPIC guideline. 54 There are 36 SLCO1B1 alleles of 29 SNPs. *1A and *1B are normal function alleles. *5, *15, and *17 are identified as decreased function alleles. The remaining alleles are annotated as possible, unknown or unclear function alleles.

DATA AVAILABILITY
The summary information from the ChinaMAP, including the position, reference allele, mutated allele and allele frequencies of all variants could be accessed through the ChinaMAP browser (www.mBiobank.com). Researchers can gain access to the data online. The sequencing data from the ChinaMAP have been deposited in the database of the National Clinical Research Centre for Metabolic Diseases in Ruijin Hospital, Shanghai, following the regulations of the Human Genetic Resources Administration of China (HGRAC). The sequencing data and information of the research participants are not publicly available to prevent the disclosure of individuals' genetic identity. Further analysis of sequencing data will be made available for collaborating researchers upon request, dependent of the HGRAC's approval.